CAR-T Cancer Treatment Draws Patients to China as Costs Rise in U.S.
Patients from the U.S., New Zealand and other high-income countries are traveling to Shanghai for chimeric antigen receptor T-cell (CAR-T) therapy, a personalized cell treatment for certain cancers.
Read Full Article: https://www.naturalnews.com/2026-09-09-car-t-cancer-treatment-draws-patients-china.html
